Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Not applicableStudy completedNCT04376814
What this trial is testing

Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19

Who this might be right for
COVID-19FavipiravirKaletra+2 more
Baqiyatallah Medical Sciences University 40
Post-approval studies (Phase 4)Study completedNCT01116817
What this trial is testing

Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy

Who this might be right for
HIV
Germans Trias i Pujol Hospital 35
Post-approval studies (Phase 4)Study completedNCT02348177
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Drugs for Neglected Diseases 96
Not applicableStudy completedNCT05024006
What this trial is testing

Public Health Emergency: SOLIDARITY TRIAL Philippines

Who this might be right for
Covid19
University of the Philippines 1,314
Not applicableStudy completedNCT02581202
What this trial is testing

The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

Who this might be right for
HIV-1 Infection
AbbVie 216
Early research (Phase 1)Study completedNCT01660477
What this trial is testing

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Who this might be right for
Pharmacokinetics of IsavuconazolePharmacokinetics of Lopinavir/RitonavirHealthy Volunteers
Astellas Pharma Global Development, Inc. 68
Not applicableEnded earlyNCT04138199
What this trial is testing

Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Who this might be right for
HIV-1 Infection
AbbVie 239
Large-scale testing (Phase 3)Study completedNCT01002898
What this trial is testing

Ritonavir-boosted Lopinavir Monotherapy

Who this might be right for
HIV
Bamrasnaradura Infectious Diseases Institute 40
Post-approval studies (Phase 4)Study completedNCT00869700
What this trial is testing

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Who this might be right for
HIV InfectionsMalaria
University of Cape Town 18
Large-scale testing (Phase 3)Study completedNCT00004583
What this trial is testing

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
Abbott 660
Post-approval studies (Phase 4)Study completedNCT01581853
What this trial is testing

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Who this might be right for
HIV
Daniel Podzamczer 21
Testing effectiveness (Phase 2)Study completedNCT00116636
What this trial is testing

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Who this might be right for
HIV Infections
Therapeutic Concepts 40
Not applicableStudy completedNCT00028314
What this trial is testing

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Who this might be right for
HIV InfectionsLipodystrophyWasting Disease
National Institute of Allergy and Infectious Diseases (NIAID) 150
Large-scale testing (Phase 3)Study completedNCT02150993
What this trial is testing

First-Line Treatment for HIV-2

Who this might be right for
HIV-2 Infection
ANRS, Emerging Infectious Diseases 210
Early research (Phase 1)Looking for participantsNCT05334004
What this trial is testing

Lopinavir/Ritonavir in PLWH With High-Grade AIN

Who this might be right for
High-Grade Anal Intraepithelial Neoplasia
University of Wisconsin, Madison 21
Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Testing effectiveness (Phase 2)Study completedNCT00036452
What this trial is testing

Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 402
Large-scale testing (Phase 3)Study completedNCT00004581
What this trial is testing

Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

Who this might be right for
HIV Infections
Abbott 300
Not applicableStudy completedNCT00571961
What this trial is testing

Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)

Who this might be right for
HIV Infections
Yale University 12
Next Page